The small and large intestine


Introduction

Any individual can reasonably expect to suffer infrequent gastrointestinal (GI) symptoms. Most disorders are self-limiting, benign conditions, but serious pathology can have enigmatic symptoms or none until a late stage in the natural history of the disease. Infective diarrhoea most commonly affects the young; inflammatory conditions affect those in early and middle adulthood; and cancer and diverticular disease affect those in middle and old age. There are similarities in presenting symptoms, and it is usually not possible to differentiate underlying causes from clinical assessment alone. Thus self-resolving disorders, in which watchful waiting is appropriate, may be indistinguishable from those requiring timely investigation and active management. Investigation can be potentially harmful as it may involve invasive procedures such as colonoscopy or radiation exposure. Careful history and examination, informed by knowledge of the hierarchy of likely age-related diagnoses, are essential when assessing such patients.

17.1 Summary

Clinical assessment of a patient with gastrointestinal symptoms

  • GI symptoms are very common

  • Most symptoms are due to self-resolving illness

  • Patient age is an important factor when considering differential diagnoses

  • Duration of symptoms is important in deciding the need for investigation

  • Careful assessment of the nature and severity of symptoms is important and may indicate peritonitis, obstruction or severe inflammation

  • Symptoms of self-resolving intestinal disorders that are managed conservatively often cannot be differentiated from major problems

  • Investigation includes blood tests, stool culture, endoscopy, imaging and open or laparoscopic inspection

Surgical anatomy and physiology

The midgut is supplied by the superior mesenteric artery and comprises the duodenum distal to the ampulla of Vater, small bowel, right colon and right two-thirds of transverse colon. The hindgut is supplied by the inferior mesenteric artery and includes the distal third of the transverse colon to rectum.

Anatomy and function of the small intestine

The small bowel extends from the pylorus to the ileocaecal valve and ranges in length from 3 to 7 metres. The jejunum comprises two-fifths of the small intestine and is of wider calibre than the ileum. The gut diameter narrows progressively from the duodenojejunal flexure to the ileocaecal valve. The small bowel mucosa is supported by a strong submucosa and comprises a single layer of columnar cells in a villiform structure that greatly increases the absorptive surface area. Columnar glandular epithelium is interspersed with mucus-secreting cells, Paneth cells and amine precursor uptake and decarboxylation (APUD) cells derived from the neural crest. Between the inner layer of circular muscle and outer longitudinal layer runs Auerbach myenteric plexus comprising vagal parasympathetic fibres and sympathetic fibres from the lesser and greater splanchnic nerves. This plexus controls orderly propulsive contractions of the muscular layers of the gut wall. The submucosal (Meissner) neuronal plexus of autonomic nerves innervates the glandular cells in the epithelium. The sensation of visceral pain is mediated by the sympathetic nervous system, originating mainly from the thoracolumbar outflow and fed along the arterial supply to the gut.

The arterial supply to the small intestine is via the superior mesenteric artery, which runs in the root of the small bowel mesentery, supplying the bowel with a series of arterial arcades ( Fig. 17.1 ). These midgut vessels communicate with the coeliac axis through the pancreaticoduodenal arcade and with the inferior mesenteric artery by contributing to the colonic marginal artery through the left branch of the middle colic artery, which joins the ascending branch of the left colic artery. Venous blood drains via the superior mesenteric vein to the portal vein. Lymphoid aggregates in the submucosa (Peyer patches) are more numerous in the ileum, and lymph drains to regional nodes in the root of the mesentery before passing to the cisterna chyli.

Fig. 17.1, Arterial arcades supplying the small intestine from the superior mesenteric artery.

The main function of the small bowel is nutrient absorption (amino acids, short peptides, sugars, fats, minerals, vitamins and micronutrients). Its secretory and digestive functions supplement those of the upper GI tract. The mucosa is thrown into circular folds (plicae semilunares) and is carpeted by finger-like villi, giving an absorptive area of 200 to 500 m 2 . Some 5 to 8 L of fluid enter the jejunum each day, of which only 1 to 2 L normally pass to the colon.

Anatomy and function of the large intestine and appendix

The main function of the large intestine is water absorption and to act as a reservoir until defaecation is appropriate. The large bowel mucosa consists of columnar epithelium interspersed with mucus-secreting goblet cells that secrete lubricating mucus. The villi are shorter than those of the small intestine, and crypts pass down to the muscularis mucosa, which is supported by a strong submucosa. The large bowel extends from the ileocaecal valve to the upper anal canal (approximately 1.6 metres). The caecum is a blind pouch at the most proximal part of the large bowel. The transverse and sigmoid colon are mobile because they have a mesentery, whereas the ascending and descending colon are only partially peritonealised. The true rectum is demarcated by coalescence of the three taeniae coli of the sigmoid colon to form a continuous outer longitudinal muscular tube. The upper third of the rectum has a peritoneal cover anteriorly and on both sides; the middle third is peritonealised only anteriorly; and the lower third is normally wholly extraperitoneal.

The inferior and superior mesenteric arteries supply the colon via a marginal artery ( Fig. 17.2 ) that allows collateral supply in the event of arterial occlusion but is weakest at the splenic flexure. In contrast to the small bowel, each of the terminal arterial branches feeding the large bowel are end arteries that has implications for the risk of ischaemia. The superior rectal artery is the continuation of the inferior mesenteric artery and, with the middle and inferior rectal arteries (branches of the internal iliac arteries), supplies the rectum. The inferior mesenteric vein drains into the splenic vein. Lymph channels run along the course of the arterial supply ( Fig. 17.2 ). Lymph from the rectum, sigmoid and descending colon drains to the superior rectal and inferior mesenteric nodes, whereas anal canal lymph drains to inguinal nodes. Knowledge of the lymphatic drainage has considerable relevance to the management of patients with rectal or anal cancers.

Fig. 17.2, Blood supply of the large intestine from the branches of the superior and inferior mesenteric arteries, with the lymphatic drainage of the colon and rectum.

The appendix is lined by colonic epithelium but has no known function in humans. The submucosa contains prominent lymphoid follicles in childhood that regress in adolescence. In older patients, the lumen may be obliterated by fibrosis. The appendix projects from the medial wall of the caecum some 2 cm below the ileocaecal junction as the taeniae coli converge.

Clinical assessment of the small and large intestine

Clinical history taking

Painful contraction of the midgut secondary to obstruction or inflammation results in periumbilical colic due to referred pain related to its the embryologic origin. Nausea, vomiting and pain are early and predominant features of many small bowel disorders, particularly obstruction. Disorders affecting the hindgut frequently present with poorly defined features including abdominal distension, colicky lower abdominal pain and altered bowel habit. Vomiting is a late feature of large bowel obstruction. Normal stool frequency is variable and ranges from one motion in 3 days to 3 motions/day. Hence, it is important to establish if there has been any change in frequency from the patient’s normal habit. Passage of blood or mucus by rectum is a common feature of large bowel disease. It is important to differentiate ‘outlet-type’ bleeding (from the anal canal) from sinister blood loss when the blood is mixed with stool; there may also be associated altered bowel habit or tenesmus (a painfully urgent but ineffectual attempt to pass stool). Outlet bleeding is typically bright red and may be present only on toilet paper or spattered in the pan, separate from the stool. There may be associated perianal pain due to fissure or prolapsed piles. Blood originating from the distal bowel is usually bright red, whereas blood coming from the upper GI tract is usually altered by gut bacteria and digestive enzymes, becoming black or tarry (melaena). Weight loss, malaise and anaemia are common nonspecific features of intestinal disease. A careful drug history is essential as many medicines can cause GI upset, both directly and indirectly.

Examination

The hands, fingernails, eyes, conjunctivae and oral mucous membrane should be inspected. Abdominal examination may reveal distension, a mass or visible peristalsis. In thin subjects, the caecum is often palpable, and the descending and sigmoid colon may be palpable when loaded with faeces. Hepatomegaly due to metastatic disease should be excluded. Abdominal auscultation is rarely of any value and has been shown to be nondiscriminatory. Digital rectal examination may detect a rectal tumour and reveal blood or mucus. In patients with lower GI symptoms, there is no rationale for checking the faeces for occult blood, as the sensitivity of the faecal occult blood (FOB) test is low. The more specific and sensitive faecal immunologic testing (FIT) may have a place in stratifying symptomatic patients for investigation.

Investigation of the luminal gastrointestinal tract

Investigation of persisting diarrhoeal illnesses should include stool samples for faecal calprotectin (nonspecific test of intestinal inflammation), culture and testing for Clostridium difficile toxin. For recent foreign travel, hot stool should be assessed for cysts, ova and parasites. Imaging modalities for small bowel comprise plain radiography, magnetic resonance imaging (MRI) enteroclysis, computed tomography (CT), capsule video endoscopy, labelled white cell radionuclide scanning and labelled red cell radionuclide scanning. Barium follow-through and contrast small bowel enema have largely been superseded by MRI. Fibreoptic small bowel enteroscopy allows direct inspection of the proximal jejunum, whereas the terminal ileum can be inspected and biopsied at colonoscopy. Coeliac disease may be diagnosed by serum ELISA assays for autoantibodies, including antiendomysial IgA antigliadin or tissue transglutaminase (tTG) antibodies. Duodenal biopsy taken at endoscopy is the gold standard investigation and would reveal the characteristic subtotal villous atrophy of coeliac disease. Tests of absorptive capacity are rarely performed. Bacterial overgrowth can be assessed using the glucose, 14 C-xylose and 14 C-glycocholate breath tests. Small bowel aspiration can be carried out by nasojejunal tube or at enteroscopy for bacterial culture.

Following digital rectal examination, direct inspection includes proctoscopy, rigid sigmoidoscopy, flexible sigmoidoscopy and colonoscopy. These techniques allow biopsy and snare removal of colorectal polyps using cauterising diathermy. Plain radiography is used extensively in an emergency. CT double-contrast colonography has superseded double-contrast barium enema. CT also has considerable utility in the assessment of the acute abdomen. CT of the chest, abdomen and pelvis is routinely used in staging of colon and rectal cancer, along with MRI for rectal cancer. Positron emission tomography (PET) after administering a 18 F-labelled tracer (fluorodeoxyglucose) that is metabolised by tumours is reserved for staging of colorectal cancer when multiorgan resection is being considered. Colonic transit can be assessed in cases of suspected megacolon or slow-transit constipation by administering radioopaque markers or ingestion of radionucleotide ( 111 In or 99 Tc)-labelled feed to assess large bowel transit time.

Principles of operative intestinal surgery

The nutritional function of the small bowel is crucial, so the principle of resectional surgery is to maximise residual bowel length. Conversely, loss of the large bowel can be tolerated with little impact on nutritional status, but water and salt depletion can occur, especially in hot climates. Specific nutritional deficits can follow resection.

Small intestinal anastomoses heal well due to their excellent blood supply and rich submucosal arteriolar plexus. The large intestine microcirculation consists of a series of small end-arteries. This feature, combined with the presence of faeces with a high density of bacterial colonisation, results in poor anastomotic healing and increased anastomotic leak rates compared with small intestine. There is a tendency towards formation of a stoma in the emergency setting due to the increased risk of anastomotic leakage, but efforts are made to reconstitute large bowel continuity in both elective and emergency resectional surgery to avoid stomas.

Mechanical bowel preparation is no longer indicated for elective large bowel resections. Low-residue diet prior to surgery may have a place, whereas broad-spectrum antibiotic prophylaxis (e.g., gentamicin, amoxicillin and metronidazole) to cover coliforms and anaerobic bacteria is essential.

Disorders of the appendix

Appendicitis

Acute appendicitis remains the most common acute abdominal emergency in childhood, adolescence and early adult life ( Chapter 13 ).

Appendiceal tumours

Tumours of the appendix

The appendix is the most common site for carcinoid tumours, which are neuroendocrine tumours (NETs), arising from the argentaffin cells of the APUD system that have an embryologic origin from the neural crest. Tumours are typically yellow submucosal lesions located near the tip of the appendix and account for 85% of all tumours and are found in 0.5% of all appendices removed for appendicitis. Most are benign, but tumours >2 cm in diameter have a greater risk for mural infiltration and lymphatic spread to the mesenteric glands. It is rare for appendiceal carcinoid tumours to give rise to liver metastases and the carcinoid syndrome. Appendicectomy is sufficient treatment for most appendiceal carcinoid tumours, but right hemicolectomy is advised for tumours >2 cm, if it involves the caecum or if the lymph nodes are affected.

Benign tumours include adenoma and cystadenoma. A mucocoele may arise due to chronic obstruction of the appendix base and luminal accumulation of mucin. It may be confused on imaging with a tumour but is cured by appendicectomy.

Pseudomyxoma peritonei

This rare condition results from mucus-secreting cells from an appendiceal cystadenoma seeding the peritoneal cavity. It is important to differentiate the disorder from a true malignant mucus-secreting adenocarcinoma. In pseudomyxoma, the peritoneal tumour has a low mitotic rate but causes pressure symptoms owing to the amount of mucin produced. Median survival is 2.5 years, and few patients are alive after 5 years. Surgical debulking is frequently necessary but rarely curative. The lesions are not responsive to conventional chemotherapy or radiotherapy. Extensive pseudomyxomas may be treated with radical cytoreductive resection with peritoneal stripping and intraoperative intraperitoneal hyperthermic chemoperfusion (HIPEC) using hot mitomycin C.

Adenocarcinoma of appendix

This rare, highly malignant neoplasm frequently presents with involved regional lymph nodes at diagnosis. The presentation may mimic acute appendicitis or appendix mass. Right hemicolectomy is the treatment of choice, even in cases where the diagnosis is only apparent at histologic assessment of an appendicectomy specimen. Adjuvant chemotherapy may be considered when lymph nodes are involved. Adenocarcinoma often affects younger patients and may arise in association with the autosomal dominant Lynch syndrome (see later).

17.2 Summary

Tumours of the appendix

  • 85% of all appendiceal neoplasms are carcinoid tumours; the appendix is the most common site of carcinoid tumour in the GI tract

  • Carcinoid tumours are found in 0.5% of surgically removed appendices

  • Carcinoids >2 cm have a greater risk of malignancy, but lymph node involvement is rare and metastases are extremely rare

  • Appendix adenocarcinoma is rare and may be associated with hereditary nonpolyposis colorectal cancer (HNPCC)

  • Mucin-secreting cystadenoma, if ruptured, may lead to pseudomyxoma peritonei

  • Pseudomyxoma peritonei is a rare, unpredictable condition that causes pressure symptoms on intestine and other intraabdominal organs, and for which there is no curative therapy, but radical cytoreductive surgery with HIPEC has gained favour

Inflammatory bowel disease

Crohn disease and ulcerative colitis may be considered together due to similarities in clinical presentation and management ( Table 17.1 ). Ulcerative colitis affects the colon and rectum exclusively, whereas Crohn disease may affect any part of the GI tract. Inflammation is restricted to the mucosa in ulcerative colitis, but transmural inflammation is a hallmark of Crohn disease. Surgery for ulcerative colitis can be curative, whereas Crohn disease frequently follows a relapsing course, despite medical or surgical intervention.

Table 17.1
Clinical features of Crohn disease and ulcerative colitis
Crohn disease Ulcerative colitis
Incidence 5–7 per 100,000 and rising 10 per 100,000 and static
Extent May involve entire gastrointestinal tract Limited to large bowel
Rectal involvement Variable Almost invariable
Disease continuity Discontinuous (skip lesions) Continuous
Depth of inflammation Transmural Mucosal
Macroscopic appearance of mucosa Cobblestone, discrete deep ulcers and fissures Multiple small ulcers, pseudopolyps
Histologic features Transmural inflammation, granulomas (50%) Crypt abscesses, submucosal chronic inflammatory cell infiltrate, crypt architectural distortion, goblet cell depletion, no granulomas
Presence of perianal disease 75% of cases with large bowel disease; 25% of cases with small bowel disease 25% of cases
Frequency of fistula 10–20% of cases Uncommon
Colorectal cancer risk Elevated risk (relative risk = 2.5) in colonic disease 25% risk over 30 years for pancolitis
Relationship with smoking Increased risk, greater disease severity, increased risk of relapse and need for surgery Protective, first attack may be preceded by smoking cessation within 6 months

Crohn disease

Although originally described as affecting the terminal ileum, any part of the GI tract can be involved, from mouth to anus. In 50% of cases, both small and large bowel are involved, whereas in 25% of cases, large bowel alone is affected. The incidence is increasing in developed countries, and the annual incidence rate is 5 to 7 cases per 100,000 in the UK. Due to the lifelong nature of the condition, the estimated UK prevalence is around 620,000 people. At the time of initial presentation, the clinical and histologic features may be indistinguishable from those of ulcerative colitis, leading to the diagnostic category of inflammatory bowel disease unclassified (IBDU). The outcome from IBDU is worse and may follow a course that eventually leads to overt evidence of Crohn disease.

Cigarette smoking is the single most important risk factor, being associated with increased disease severity, likelihood of relapse and further need for surgical interventions. There is also evidence for the involvement of immunologic factors and the gut bacterial flora in Crohn disease pathogenesis. There is a substantial heritable contribution to disease aetiology, variously estimated at 20–50%.

Pathology

Macroscopically, Crohn disease produces a cobblestone appearance, in which oedematous islands of mucosa are separated by fissures that can extend through all coats of the bowel wall. Circumferential ulceration and associated fibrosis can result in multiple strictures of varying length. Multiple areas of inflammation are common with intervening normal bowel (skip lesions, Fig. 17.3 ). Full thickness involvement of the bowel wall leads to serosal inflammation, adhesion to neighbouring structures and sinus or fistula formation. Microscopically, there are deep fissuring ulcers, oedema and inflammatory cell infiltrates, with foci of lymphocytes and noncaseating granulomas in 50% of cases.

Fig. 17.3, Small bowel follow-through showing Crohn disease strictures ( arrow indicates long stricture).

Clinical features

Crohn disease is a chronic disorder with exacerbations, remissions and a varied clinical presentation. Continuous or episodic diarrhoea is associated with recurring abdominal pain and tenderness, lassitude and fever. There may be declining general health, malabsorption, weight loss and metabolic bone disease (osteoporosis or osteomalacia). Failure to thrive and reach developmental milestones are common in affected children.

Examination may reveal malnutrition, and there may be a palpable abdominal mass. Intestinal obstruction may be due to gross thickening of active disease occluding the lumen, stricturing of ‘burnt out’ disease or adhesions from previous surgical intervention. Fistula formation occurs in 20% of patients with small and large bowel disease but less in those with disease restricted to the large bowel. Fistulae may communicate with adjacent loops of bowel, other viscera (e.g., bladder, vagina) or the skin. Enterocutaneous fistulae may result from surgical intervention and commonly involve the anterior abdominal wall or perineum ( Fig. 17.4 ). Abscesses can result from chronic bowel perforation, but free perforation is relatively uncommon because the inflamed segment usually adheres to surrounding structures. Although less common than in ulcerative colitis, toxic dilatation can complicate colonic disease. Fulminant Crohn colitis with severe inflammation, mucosal oedema, deep linear ulcers and fibrosis is shown in Fig. 17.5 .

Fig. 17.4, Severe perianal Crohn disease with fistulation.

Fig. 17.5, Fulminant Crohn colitis.

There is an elevated risk of colorectal adenocarcinoma with long-standing Crohn disease: 2.5-fold overall and 4.5-fold for colonic disease, with a 10-year cumulative risk following diagnosis of 2.9%. Lymphoma risk may also elevated, likely due to immunomodulatory therapy (e.g., thiopurines) and biological therapy (anti-TNF and antiintegrin). Evidence is limited that surveillance provides protection, and many patients with long-standing colonic Crohn eventually come to colectomy. Crohn disease is also associated with ∼30-fold excess risk of small bowel adenocarcinoma, but because that cancer is rare; the absolute risk only amounts to 0.2% at 10 years and 2.2% at 25 years after diagnosis.

Anorectal involvement is common (25% in small bowel Crohn disease; 75% in large bowel disease), including abscess, fistula, fissures, ulceration, oedematous skin tags and anorectal stricturing. Anal fissures are often multiple and indolent, and extend to involve any part of the perineum, including the vagina or scrotum. Systemic manifestations include anterior uveitis, iritis, polyarthropathy, ankylosing spondylitis, liver disease (e.g., sclerosing cholangitis) and erythema nodosum. Terminal ileal involvement or ileocaecal resection may result in gallstone formation owing to poor absorption of bile salts.

Investigations

Assessment of nutritional status, including serial weight measurement, is essential. Anaemia may be due to iron deficiency from chronic blood loss and (rarely nowadays) malabsorption from short gut syndrome, a normocytic anaemia of chronic disease, macrocytic anaemia from vitamin B 12 or folate malabsorption. Assays for circulating acute-phase proteins (C-reactive protein) is not a diagnostic test but is useful for monitoring disease activity. Until recently, the diagnosis was most frequently made on barium follow-through ( Fig. 17.6 ), revealing rose-thorn ulcers or long irregular terminal ileal stricture at the site of previous ileocaecal resection. Active disease produces radiologic evidence of thickening, luminal narrowing and separation of bowel loops, and is often associated with mucosal ulceration, deep fissuring ulcers and cobblestone appearance. Skip lesions and fistula formation may be apparent. MRI enteroclysis (image enhanced by administering oral osmotically active agent, e.g., polyethylene glycol) is now the investigation of choice ( Fig. 17.7 ) and has the advantage of limiting radiation exposure. Rectal examination, proctoscopy, sigmoidoscopy and colonoscopy determine disease extent, and biopsy of inflamed bowel is mandatory. Newer investigative techniques include video capsule endoscopy ( Fig. 17.8 ), enteroscopy and CT colonography. Double-contrast radiography still has a place for delineation of fistulous tracts.

Fig. 17.6, Small bowel contrast enema in Crohn disease, showing a long irregular stricture ( arrowed ) and typical rose-thorn ulceration.

Fig. 17.7, Small bowel magnetic resonance imaging showing thickened strictured small bowel in Crohn disease ( arrow ).

Fig. 17.8, Video capsule enteroscopy of Crohn disease.

Management

Medical management

Attention to general nutritional state is crucial. Anaemia should be corrected by transfusion, iron and/or vitamin supplements, as appropriate. Oral protein and calorie supplements may be required, and patients with short bowel syndrome may require intravenous nutrition. Bile salt diarrhoea secondary to previous terminal ileal resection may benefit from cholestyramine.

Corticosteroids may be used to induce remission (prednisolone 30–60 mg daily by mouth), but long-term therapy should be avoided. Some patients with colonic disease or relapsing terminal ileal disease may be maintained on 5-aminosalicylic acid agents (e.g., mesalazine, olsalazine), but there is no evidence that prophylactic maintenance therapy reduces relapse risk or need for further surgery. Immunosuppression using azathioprine or 6-mercaptopurine can be used in resistant cases to induce remission and for maintenance. There are concerns about complications of long-term immunosuppression; the agents are not generally continued beyond 2 years without review and are seldom used beyond 4 years. Monoclonal antibodies to tumour necrosis factor-α (TNF-α) (e.g., Infliximab) and humanised anti-TNF MAbs (Adalimumab) are now widely used. Newer biological agents are under development, and those such as the gut-selective monoclonal antibody to alpha integrin (Vedolizumab, Etrolizumab) are widely used as second line therapy. Ustekinumab is a monoclonal antibody to the p40 subunit of IL-12 and IL-23 and has been approved for treatment of moderate and severe disease. Other agents in use include Tofacitinib (oral JAK inhibitor) and Ozanimod (oral S1P receptor modulator).

Surgical management

Many patients undergo surgery at some stage of their disease course, and multiple operations are common. There are four main categories of indications for surgical management of Crohn disease:

  • 1.

    Onset of complications of luminal disease: fulminant colitis, life-threatening haemorrhage, obstruction, abscess/sepsis, perforation, fistulation.

  • 2.

    Acute or chronic failure of medical management to control symptoms/disease activity, failure to thrive, complications of medical therapy.

  • 3.

    Treatment or prophylaxis of malignancy.

  • 4.

    Perianal disease: abscess, fistula, anorectal stricture ( EBM 17.1 ).

Preservation of bowel length is paramount, by limiting segmental bowel resection and using stricturoplasty (longitudinal enterotomy with transverse closure of strictures). Measured length of residual small bowel should be documented. Relapse is common following small bowel resection, but small bowel relapse occurs in less than 20% of patients with exclusively colonic disease. However, many patients with colonic disease eventually come to proctocolectomy and permanent ileostomy. In perianal Crohn disease, loculated pus must be drained, and radical surgery should be avoided. Simple fistulae may be laid open, but long-term Seton drainage is used for complex fistulae involving sphincter muscle. Complex reconstructions such as rectal advancement flaps should be avoided.

17.3 Summary

Indications for surgery in Crohn disease

Elective

  • Chronic subacute obstruction due to fibrotic strictures, adhesions or refractory disease

  • Symptomatic disease unresponsive to, or poorly controlled by, medical management

  • Chronic relapsing disease on discontinuation of medical management and steroid dependency

  • Complications of medical management (e.g., osteoporosis)

  • Concerns about long-term immunosuppression, risk of malignancy and viral/atypical infections

  • Perianal sepsis and fistula

  • Enterocutaneous fistula

  • Onset of malignancy, including colorectal adenocarcinoma and small bowel lymphoma

  • Rarely, control of debilitating extracolonic manifestations such as iritis and sacroiliitis

Emergency

  • Fulminant colitis or acute small bowel relapse unresponsive to medical management

  • Acute bowel obstruction

  • Life-threatening haemorrhage

  • Abscess or free perforation

  • Perianal abscess

Ulcerative colitis

The annual incidence of ulcerative colitis is ∼10/100,000 population in Westernised countries but rare in developing countries. The aetiology is incompletely understood, but genetic, immunologic and dietary factors all play a part. Any age group may be affected, but peak incidence is in early adulthood. The disease may be contiguous but almost universally affects the rectum and extends proximally ( Table 17.1 ). In a minority, the rectum may be spared, and in untreated patients, this should raise suspicion about underlying Crohn disease. There is an elevated risk of adenocarcinoma in ulcerative pancolitis. Although ulcerative colitis is primarily a disease of the large bowel, systemic manifestations (iritis, polyarthritis, sacroiliitis, hepatitis, erythema nodosum, pyoderma gangrenosum) can occur. Sclerosing cholangitis affects 2–5% of patients with ulcerative colitis and may necessitate liver transplantation.

Pathology

The characteristic feature is inflammation restricted to the mucosa and submucosa of the large bowel. In severe episodes, there may be full-thickness involvement with inflammatory infiltrate. Abscesses develop at the base of the colonic crypts, which burst and unite to form crypt abscesses. These undermine the mucosa, resulting in ulceration

Lamb CA et al. Gut. 2019;68:s1–s106. https://doi.org/10.1136/gutjnl-2019-318484 .
EBM 17.1
Crohn disease and ulcerative colitis

‘IBD patients with colonic disease should be offered ileocolonoscopy 8 years after symptom onset to screen for neoplasia, to determine disease extent and decide on the frequency of ongoing surveillance.’

‘Surgery in acute severe ulcerative colitis is indicated when the disease is medically resistant, there are intolerable side effects of medication, or when there is life-threatening haemorrhage, toxic megacolon or perforation.’

‘Surgical resection of the colon and rectum in ulcerative colitis should be offered to patients who have chronic active symptoms despite optimal medical therapy. Ileoanal pouch reconstruction or end ileostomy provide equivalently good quality of life, and are a matter of patient choice.’

( Fig. 17.9 ) and oedema of the intervening mucosa, with formation of inflammatory pseudopolyps. Histologically, there is also chronic inflammatory cell infiltrate, crypt architectural distortion and goblet cell depletion. Granulomas are absent but are occasionally present in severe cases, causing diagnostic difficulties. The thickened colon loses its haustrations and becomes rigid. Stricturing is rare, so its presence should raise the possibility of cancer or Crohn disease.

Fig. 17.9, Resected colonic specimen of fulminant ulcerative colitis showing denuded colonic epithelium ( arrow ).

Clinical features

Ulcerative colitis characteristically runs a relapsing/remitting course, although some patients may have a chronic continuous variant. The initial attack may be fulminant, and toxic dilatation with exacerbation of abdominal and systemic symptoms may occur at any time. Diarrhoea with the passage of mucus and blood is typical of relapse. Abdominal pain and tenderness may be present, and intermittent pyrexia is common. Daily passage of 10 to 15 or more stools is not unusual in acute severe exacerbations. Incapacitating faecal urgency is the main symptom that degrades quality of life.

Careful rectal examination should be performed to detect anal complications such as fissure, fistula and haemorrhoids (present in 25% of cases); the rectal mucosa typically feels thick and boggy. Sigmoidoscopy and biopsy are essential and reveals red, granular mucosa with contact bleeding. In the early stages, sigmoidoscopy may only show loss of rectal mucosal vessels. As the disease progresses, severe ulceration leads to fulminant colitis, the complications of which include nutritional depletion, toxic dilatation, perforation and bleeding. During an exacerbation, the dilated colon may become paper-thin. Recent population-based studies have revealed that the mortality for all inpatient admissions for ulcerative colitis is ∼15% at 3 years, emphasising the severity of the disorder.

Investigations

In the acute phase, stool cultures are essential to exclude supervening bacterial infection (especially C. difficile ). Colonoscopy is the mainstay of diagnosis and assessment of disease extent/severity ( Fig. 17.10 ). Abdominal CT should be reserved for suspected perforation to minimise radiation exposure. Typical changes include loss of haustrations, fluffy granularity of the mucosa and pseudopolyps. Undermining ulcers may create a double contour to the edge of the colon. Widening of the retrorectal space due to perirectal inflammation and reduced distensibility of the rectum is common. In long-standing colitis, the bowel may become short and featureless, resembling a smooth tube (‘lead-pipe’ colon). In an acute attack, plain films of the abdomen may reveal a dilated gas-filled colon in which pseudopolyps are evident (‘thumb printing’). When toxic dilatation is suspected, daily plain x-rays are mandated ( Fig. 17.11 ). ‘Backwash ileitis’ may produce a dilated and featureless terminal ileum in which the mucosa appears granular and can lead to diagnostic difficulties with Crohn disease.

Fig. 17.10, Colonoscopic appearance of severe acute colitis.

Fig. 17.11, Plain abdominal radiograph of fulminant colitis showing distension and mucosal oedema and thumb printing ( arrows ).

Management

Medical

Repeated clinical and laboratory assessment is key during an acute exacerbation to identify those with a severe episode that requires escalation of therapy and/or surgical resection. Daily stool charting, temperature and pulse, along with C-reactive protein and albumin assays, are essential. Various criteria are used to identify those with a severe episode, and these include Truelove and Witt’s score: stool frequency >6 ×/24 h AND any of Hb <105 g/L, ESR (erythrocyte sedimentation rate) >30 mm/h, pulse >90 bpm, T >37.5°C.

Fluid and electrolyte replacement, correction of anaemia, nutritional support, intravenous corticosteroid therapy and timely surgical intervention are the mainstay of treatment of an exacerbation. High-dose systemic steroids are needed during an acute relapse. In fulminant colitis unresponsive to steroid therapy, it is now standard of care to escalate therapy to immunosuppression with cyclosporin A or biological therapy with anti-TNF agents (e.g., Infliximab). Topical steroids delivered by enema or suppository usually control mild attacks of proctocolitis. Long-term aminosalicylates, such as mesalazine or olsalazine, reduce the risk of relapse once a remission has been induced. Azathioprine is also used for maintenance therapy. Around 15% of all patients diagnosed with ulcerative colitis will eventually require surgery; 1 in 50 for mild proctitis, 1 in 20 for moderately severe colitis and 1 in 2 for extensive disease.

Surgical

Indications for surgery in the emergency setting include fulminant colitis that fails to respond to aggressive medical therapy, perforation and toxic dilatation. The primary aim of monitoring is to operate before perforation occurs when mortality increases dramatically. Patients presenting as an emergency are catabolic, malnourished, immunosuppressed, bacteraemic and septic. Hence, surgical reconstruction in the acute phase is inadvisable, and management comprises colectomy and ileostomy as a ‘first aid’ operation. The rectum is closed over as a stump in the pelvis or by bringing out the distal end as a mucous fistula. Completion proctectomy and the formation of an ileoanal pouch are undertaken ∼6 months following the emergency operation to allow nutritional recovery. The residual rectum is removed because of the elevated rectal cancer risk over the remaining lifetime.

Indications for elective surgery include failure of medical management or repeated relapses on medical treatment. Failure to thrive, as reflected in retardation of growth and sexual development in children or malnourishment and anaemia in adults, is a common indication for operation. The onset of biopsy-proven dysplasia or carcinoma in chronic disease necessitates surgical intervention.

Modern surgical practice comprises restorative proctocolectomy with retention of anal sphincters and reconstruction with an ileal pouch anastomosed to the upper anal canal to maintain the ability to defaecate. A temporary ileostomy may be required. Median stool frequency is four to six liquid or soft motions/day, but the debilitating faecal urgency associated with colitis is eliminated, and the overall quality of life is excellent. Where pouch anal anastomosis is not possible, a Koch continent ileostomy may be considered. Proctocolectomy and permanent end ileostomy still have an important place in management.

17.4 Summary

Indications for surgery in ulcerative colitis

Elective

  • Symptomatic disease unresponsive to, or poorly controlled by, medical management

  • Chronic relapsing disease on discontinuation of medical management and steroid dependency

  • Complications of medical management

  • Concerns about long-term immunosuppression, risk of malignancy and viral/atypical infections

  • Severe dysplasia on surveillance biopsies of colorectal epithelium

  • Onset of colorectal adenocarcinoma

  • Rarely, control of debilitating extracolonic manifestations such as iritis and sacroiliitis

Emergency

  • Fulminant colitis unresponsive to maximal medical management

  • Toxic megacolon

  • Free perforation

  • Life-threatening haemorrhage

  • Acute complications of medical management

Cancer surveillance in ulcerative colitis

Colorectal cancer risk in long-standing ulcerative colitis is a major factor contributing to surgical decision making. Carcinoma is typically difficult to detect, is usually poorly differentiated and has a poor prognosis. Historical data indicate that 2% of patients develop cancer at 10 years, 8% at 20 years and 18% at 30 years (25% in patients with pancolitis). Early age at first onset (<15 years), pancolitis, a family history of colorectal cancer and associated primary sclerosing cholangitis (PSC) are strong cancer risk factors. However, recent evidence suggests that overall cancer risk may be lower due to aggressive suppression of inflammation by newer agents. Nonetheless, twice-yearly colonoscopic surveillance with random colonic biopsies to detect dysplasia is mandated in chronic pancolitis ( EBM 17.1 ). Dysplasia-associated lesion or mass (DALM) is a high-risk indicator of impending, or concurrent, cancer development. Cancer risk for patients with high-grade dysplasia or DALM is >60% in the next 2 years, and prophylactic proctocolectomy is recommended. Even without dysplasia, patients with panulcerative colitis may opt for prophylactic restorative proctocolectomy rather than undergo life-long surveillance, especially when diagnosed in teenage years.

Disorders of the small intestine

Small bowel neoplasms

Small bowel tumours account for less than 5% of all GI neoplasms.

Benign tumours

Solitary tumours include adenomatous polyps, hamartomas, lipomas and haemangiomas. Multiple hamartomas are found in Peutz–Jeghers syndrome. Benign tumours are rarely symptomatic, so the true incidence is unknown. Symptoms may arise because of intussusception or bleeding.

Malignant tumours

Malignant small intestinal tumours are rare and frequently diagnosed late because symptoms are nonspecific, so initial presentation may be at laparotomy for small bowel obstruction. In symptomatic cases, imaging modalities include MRI enteroclysis, barium follow-through, CT, flexible enteroscopy and video capsule endoscopy.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here